drugset / Trial / NCT01050452
Safety and Efficacy of Drug Combinations Against Trichuris Trichiura
RandomizedParallel-groupDouble-blindTreatment
Summary
This randomised, controlled, double-blinded clinical study investigates the safety and efficacy of albendazole (ALB), mebendazole (MBD) and ivermectin (IVM) separately, and ALB and MBD each in combination with IVM in the treatment of Trichuris trichiura in children aged 5-14 years.
Timeline
- Start
- 2007-10
- Primary completion
- 2009-08
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Albendazole | Small molecule | 400 mg | — |
| Comparator | Ivermectin | Small molecule | 200 ug/kg | — |
| Comparator | Mebendazole | Small molecule | 500 mg | — |